AU2001230994A1 - Use of pentosan polysulfate to treat certain conditions of the prostate - Google Patents
Use of pentosan polysulfate to treat certain conditions of the prostateInfo
- Publication number
- AU2001230994A1 AU2001230994A1 AU2001230994A AU3099401A AU2001230994A1 AU 2001230994 A1 AU2001230994 A1 AU 2001230994A1 AU 2001230994 A AU2001230994 A AU 2001230994A AU 3099401 A AU3099401 A AU 3099401A AU 2001230994 A1 AU2001230994 A1 AU 2001230994A1
- Authority
- AU
- Australia
- Prior art keywords
- prostate
- certain conditions
- pentosan polysulfate
- treat certain
- treat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229940043138 pentosan polysulfate Drugs 0.000 title 1
- 210000002307 prostate Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17708300P | 2000-01-19 | 2000-01-19 | |
US60/177,083 | 2000-01-19 | ||
PCT/US2001/001837 WO2001052867A1 (en) | 2000-01-19 | 2001-01-19 | Use of pentosan polysulfate to treat certain conditions of the prostate |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001230994A1 true AU2001230994A1 (en) | 2001-07-31 |
Family
ID=22647123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001230994A Abandoned AU2001230994A1 (en) | 2000-01-19 | 2001-01-19 | Use of pentosan polysulfate to treat certain conditions of the prostate |
Country Status (4)
Country | Link |
---|---|
US (2) | US20020010140A1 (en) |
AR (1) | AR035026A1 (en) |
AU (1) | AU2001230994A1 (en) |
WO (1) | WO2001052867A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7453002B2 (en) | 2004-06-15 | 2008-11-18 | Bristol-Myers Squibb Company | Five-membered heterocycles useful as serine protease inhibitors |
US7502229B2 (en) * | 2004-10-15 | 2009-03-10 | Alcatel Lucent | Heat dissipation system for multiple integrated circuits mounted on a printed circuit board |
NZ571537A (en) | 2006-04-03 | 2012-06-29 | Nutramax Lab Inc | Stabilized pentosan polysulfate (PPS) formulations and methods of analayzing them |
AU2008100730B4 (en) | 2008-07-04 | 2008-10-02 | Parnell Technologies Pty Ltd | Sulfated polysaccharide compound for clinical use and the preparation thereof |
WO2011088418A2 (en) * | 2010-01-15 | 2011-07-21 | Mount Sinai School Of Medicine | Inhibition of tnf-alpha induced activation of nfkb by pentosan polysulfate |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5605938A (en) * | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
US5643892A (en) * | 1995-06-07 | 1997-07-01 | Baker Norton Pharmaceuticals, Inc. | Method of treating chronic progressive vascular diseases |
US5795909A (en) | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
UA65587C2 (en) * | 1997-10-09 | 2004-04-15 | Baker Norton Pharma | Method for preventing nephrotoxicity induced by cyclosporins or tacrolimus |
-
2001
- 2001-01-19 AU AU2001230994A patent/AU2001230994A1/en not_active Abandoned
- 2001-01-19 US US09/766,245 patent/US20020010140A1/en not_active Abandoned
- 2001-01-19 WO PCT/US2001/001837 patent/WO2001052867A1/en active Application Filing
- 2001-01-19 AR ARP010100243A patent/AR035026A1/en unknown
-
2002
- 2002-07-30 US US10/209,331 patent/US6828309B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2001052867A9 (en) | 2002-10-10 |
US6828309B2 (en) | 2004-12-07 |
WO2001052867A1 (en) | 2001-07-26 |
AR035026A1 (en) | 2004-04-14 |
US20030040491A1 (en) | 2003-02-27 |
US20020010140A1 (en) | 2002-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003239568A1 (en) | Pyrrolotriazinone compounds and their use to treat diseases | |
EP1613251A4 (en) | Devices, systems, and methods to fixate tissue within the regions of body, such as the pharyngeal conduit | |
EP1691760A4 (en) | Devices systems, and methods to fixate tissue within the regions of the body, such as the pharyngeal conduit | |
IL162533A0 (en) | Chalcone derivatives and their use to treat diseases | |
AU2001282717A1 (en) | Cancer treatment by combination therapy | |
AU2001249549A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
BRPI0010891B8 (en) | generation of therapeutic microfoam. | |
PT1147114E (en) | NEW ARALQUILAMINS OF UPRISING SPIROFUROPYRIDINES IN THERAPY. | |
AU2001272852A1 (en) | Composition for the treatment of migraine | |
AUPQ923100A0 (en) | Treatment of prostate cancer | |
MXPA03000188A (en) | Methods of treating neutrophil-related diseases with topical anesthetics. | |
AU2002210385A1 (en) | Furazanyl-triazole derivates for the treatment of diseases | |
NO20022245D0 (en) | Oncolytic combinations for the treatment of cancer | |
AU2001280804A1 (en) | Aldosterone blocker therapy to prevent or treat inflammation-related disorders | |
AU3086900A (en) | Device for the complex treatment of disorders of the prostate | |
MXPA03008634A (en) | Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases. | |
AU2003295336A1 (en) | Use of etodoclac to treat hyperplasia | |
ZA200003236B (en) | Combination therapy for the treatment of migraine. | |
AU2001227972A1 (en) | Methods to treat alpha-1-antitrypsin deficiency | |
AU2001266838A1 (en) | Inhibitors of matriptase for the treatment of cancer | |
MXPA03007653A (en) | Use of lp82 to treat hematopoietic disorders. | |
HK1051692A1 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain. | |
AU2002351374A1 (en) | Antibodies to treat cancer | |
AU2001230994A1 (en) | Use of pentosan polysulfate to treat certain conditions of the prostate | |
AU1916601A (en) | Oncolytic combinations for the treatment of cancer |